Introduction
============

Colon cancer is one of the most common malignancies worldwide \[[@goz033-B1]\]. In the USA, it was estimated that 97,220 new colon-cancer cases would be diagnosed in 2018 \[[@goz033-B2]\]. Surgical resection is the only curative treatment modality for colon cancer; mortality should be kept low with adequate assessment of comorbidities \[[@goz033-B3]\]. A large number of colon-cancer patients have anemia \[[@goz033-B4], [@goz033-B5]\] and pre-operative anemia has been reported to be associated with poor post-operative outcomes in patients undergoing colectomy \[[@goz033-B6]\].

Perioperative (intra- and/or post-operative) blood transfusion is sometimes necessary for colon-cancer patients with anemia who underwent surgery \[[@goz033-B7], [@goz033-B8]\]. However, the relationship between blood transfusion and post-operative outcomes is unclear, as published studies report conflicting results \[[@goz033-B9]\]. Although there are some suggestions that transfusions and pre-operative anemia are both independent predictors of a poor outcome \[[@goz033-B6], [@goz033-B13]\], no studies have investigated the joint effect of anemia and transfusion on surgical outcomes among colon-cancer patients who have undergone colectomy. Transfusions are commonly perioperatively given to patients with anemia during surgery \[[@goz033-B14]\]. Due to the strong association between anemia and transfusion, the joint effect of anemia and transfusions should be considered. Additionally, there is growing evidence that demonstrates that right colon cancer (RCC) and left colon cancer (LCC) might be different malignancies \[[@goz033-B15]\]. It is not clear whether anemia and transfusions have differential effects on RCC or LCC outcomes. Furthermore, stratification by tumor location provides an opportunity to identify patients who may benefit from a transfusion treatment. This study aimed to evaluate the combined effect of anemia and transfusion on surgical outcomes stratified by tumor location.

Material and methods
====================

Data source and study population
--------------------------------

The American College of Surgeons National Surgical Outcome Improvement Program (ACS NSQIP) database is a nationally validated, risk-adjusted, outcomes-based program used to measure and improve the quality of surgical care. A total of 39,729 patients who underwent elective laparoscopic or open colectomy for RCC or LCC were identified from the NSQIP 2006--2016 database. RCC colectomy was defined as a partial colectomy with ileocolic anastomosis (current procedural terminology \[CPT\] codes: 44160 or 44205) for a malignant neoplasm of the colon (the *International Classification of Diseases, Ninth Revision* \[*ICD-9*\] or *Tenth Revision* \[*ICD-10*\]), cecum (153.4 or C18.0), ascending colon (153.6 or C18.2), or hepatic flexure (153.0 or C18.3). LCC colectomy was defined as a partial colectomy (CPT codes: 44140, 44204, 44145, or 44207) for malignant neoplasm of the descending colon (153.2 or C18.6) or sigmoid colon (153.3 or C18.7).

Patients admitted as urgent or emergency cases; patients with missing information on hematocrit analysis or blood-transfusion details; patients with sepsis, open wounds, or wound infections; and patients dependent on a ventilator were excluded from consideration. This study was designed to compare outcomes between LCC and RCC, so the patients undergoing total colectomy were excluded.

Variable definition
-------------------

Using the pre-operative hematocrit levels, anemia was categorized as severe (hematocrit \<26%), moderate (26% to \<30%), mild (30% to \<38%), and no anemia (≥38%) according to the criteria established in a previous study \[[@goz033-B6]\]. We combined the moderate and mild anemia categories into the 'mild anemia' group according to a previous study \[[@goz033-B19]\]. Perioperative blood transfusion was defined as patients who received a transfusion any time from the start of surgery to 72 hours after surgery (intra- and/or post-operative). Minor complications included superficial surgical-site infection (SSI), urinary-tract infection (UTI), deep venous thrombosis (DVT), and thrombophlebitis. Major complications included deep SSI, organ-space SSI, wound disruption, pneumonia, re-intubation, pulmonary embolism, greater than 48-hour post-operative ventilator-assisted respiration, progressive renal insufficiency, acute renal failure (ARF), cardiovascular accident (CVA), cardiac arrest requiring cardiopulmonary resuscitation, myocardial infarction (MI), sepsis, and septic shock. Patients experiencing any complication were defined as having at least one minor or major complication.

Statistical analysis
--------------------

The baseline characteristics between RCC and LCC patients were compared using Pearson's chi-square tests for categorical variables and Student's *t*-test for continuous variables. Multivariate logistic regression models were employed to examine the associations of surgical outcomes with anemia and transfusion while adjusting for potential confounding variables. The significance of the anemia--transfusion interaction was assessed by adding an interaction term in the logistic regression models. All statistical tests were two-sided. A *P *\<* *0.05 was considered statistically significant. All statistical analyses were performed using SAS (version 9.4, SAS Institute Inc, Cary, NC, USA).

Results
=======

Demographics and comorbidities
------------------------------

After applying the exclusion criteria, 35,863 patients (18,936 LCC and 16,927 RCC) were analysed. Compared with RCC patients, LCC patients were more likely to be younger, male, non-white, and current smokers **(**[Table 1](#goz033-T1){ref-type="table"}**)**, and were also more likely to be functionally independent and have an American Society of Anesthesiologists (ASA) classification of \<3 and a body mass index (BMI) of \>30 kg/m². LCC patients experienced less weight loss and comorbidities of diabetes mellitus, MI, congestive heart failure (CHF), previous cardiac surgery, previous percutaneous coronary intervention (PCI), transient ischemic attack (TIA), hypertension, pneumonia, chronic obstructive pulmonary disease (COPD), CVA, and hemiplegia compared with RCC patients. No significant differences were observed in surgery approach and comorbidities of revascularization or amputation, renal failure, dialysis, impaired sensorium, or quadriplegia. The percentages of RCC patients who had mild anemia (62.7% vs 40.2%, respectively; *P *\<* *0.001) and severe anemia (2.9% vs 1.4%, respectively; *P *\<* *0.001) were lower than those of LCC patients. A total of 2,661 (7.4%) of all patients (1,079 \[5.7%\] with LCC and 1,582 \[9.3%\] with RCC) received a perioperative transfusion.

###### 

Distribution of 35,863 patients with colon cancer from the American College of Surgeons National Surgical Outcome Improvement Program (ACS NSQIP) database

  Characteristic                     No. of patients (%)   *P*-value       
  ---------------------------------- --------------------- --------------- ---------
  Age, years                                                               
   ≤49                               2,541 (13.4)          971 (5.7)       \<0.001
   50--64                            7,303 (38.6)          4,100 (24.2)    
   65--79                            6,627 (35.0)          7,233 (42.7)    
   ≥80                               2,465 (13.0)          4,623 (27.3)    
  Sex                                                                      
   Female                            8,841 (46.7)          9,291 (54.9)    \<0.001
   Male                              10,095 (53.3)         7,636 (45.1)    
  Race                                                                     
   White                             12,178 (64.3)         11,822 (69.8)   \<0.001
   Black                             1,680 (8.9)           1,596 (9.4)     
   Others                            5,078 (26.8)          3,509 (20.7)    
  Current smoker                                                           
   No                                16,508 (87.2)         14,948 (88.3)   0.001
   Yes                               2,428 (12.8)          1,979 (11.7)    
  Functional status                                                        
   Independent                       18,503 (97.7)         16,266 (96.1)   
   Partially or fully dependent      433 (2.3)             661 (3.9)       \<0.001
  ASA classification                                                       
   \<3                               9,050 (47.8)          6,074 (35.9)    \<0.001
   ≥3                                9,886 (52.2)          10,853 (64.1)   
  BMI, kg/m²                                                               
   \<18.5                            340 (1.8)             393 (2.3)       \<0.001
   18.5--24.9                        4,659 (24.6)          4,511 (26.7)    
   25--29.9                          6,454 (34.1)          5,784 (34.2)    
   ≥30                               7,483 (39.5)          6,239 (36.9)    
  Weight loss \>10%                                                        
   No                                18,168 (95.9)         16,000 (94.5)   \<0.001
   Yes                               768 (4.1)             927 (5.5)       
  Surgery procedure                                                        
   Laparoscopic                      11,330 (59.8)         10,005 (59.1)   0.19
   Open                              7,606 (40.2)          6,922 (40.9)    
  Comorbidities                                                            
   Diabetes mellitus                 3,499 (18.5)          3,474 (20.5)    \<0.001
   MI                                35 (0.2)              61 (0.4)        0.001
   CHF                               154 (0.8)             238 (1.4)       \<0.001
   Revascularization or amputation   78 (0.4)              68 (0.4)        0.88
   Previous cardiac surgery          335 (1.8)             410 (2.4)       \<0.001
   Previous PCI                      378 (2.0)             403 (2.4)       0.01
   TIA                               150 (0.8)             197 (1.2)       \<0.001
   Hypertension                      10,025 (52.9)         10,276 (60.7)   \<0.001
   Pneumonia                         1 (0)                 13 (0.1)        \<0.001
   COPD                              847 (4.5)             1, 112 (6.6)    \<0.001
   Renal failure                     66 (0.4)              66 (0.4)        0.52
   Dialysis                          100 (0.5)             98 (0.6)        0.52
   CVA                               110 (0.6)             147 (0.9)       0.001
   Impaired sensorium                5 (0)                 5 (0)           0.86
   Hemiplegia                        38 (0.2)              64 (0.4)        0.002
   Quadriplegia                      4 (0)                 2 (0)           0.5
  Operation approach                                                       
   Open                              7,606 (40.2)          6,922 (40.9)    0.1619
   Laparoscopic                      11,330 (59.8)         10,005 (59.1)   
  Anemia                                                                   
   No                                11,073 (58.5)         5,829 (34.4)    
   Mild                              7,602 (40.2)          10,606 (62.7)   \<0.001
   Severe                            261 (1.4)             492 (2.9)       \<0.001
  Blood transfusion                                                        
   No                                17,867 (94.4)         15,345 (90.7)   \<0.001
   Yes                               1,069 (5.7)           1,582 (9.4)     

LCC, left colon cancer; RCC, right colon cancer; ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); MI, myocardial infarction; CHF, congestive heart failure; PCI, percutaneous coronary intervention; TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident.

Association between outcomes and locations
------------------------------------------

After adjusting for patient demographics and comorbidities, there was no significant difference in complications between RCC and LCC patients **(**[Table 2](#goz033-T2){ref-type="table"}**)**. When specific complications were considered, RCC patients had higher risk of pneumonia (odds ratio \[OR\]* *=* *1.23; 95% confidence interval \[CI\]* *=* *1.04--1.45; *P *=* *0.016), re-intubation (OR* *=* *1.04; 95% CI* *=* *1.04--1.04; *P *\<* *0.001), and DVT (OR* *=* *1.28; 95% CI* *=* *1.02--1.60; *P *=* *0.033) than LCC patients. RCC patients had lower risk of wound disruption (OR* *=* *0.69; 95% CI* *=* *0.54--0.89; *P *=* *0.003), ventilator dependence (OR* *=* *0.89; 95% CI* *=* *0.89--0.89; *P *\<* *0.001), and ARF (OR* *=* *0.94; 95% CI* *=* *0.94--0.95; *P *\<* *0.001) than LCC patients. Lastly, the operation time of colectomy for RCC was shorter than that for LCC patients (OR* *=* *0.38; 95% CI* *=* *0.36--0.39; *P *\<* *0.001); however, RCC patients stayed in the hospital longer (OR* *=* *1.10; 95% CI* *=* *1.05--1.15; *P *\<* *0.001) than LCC patients.

###### 

Association between surgical outcomes and colon-cancer locations

  Outcome                                                               No. of patients (%)   OR[^a^](#tblfn3){ref-type="table-fn"} (95% CI)   *P*-value           
  --------------------------------------------------------------------- --------------------- ------------------------------------------------ ------------------- ---------
  No complication                                                       16,315 (86.2)         14,238 (84.1)                                    1 \[Reference\]     
  Any complication[^b^](#tblfn4){ref-type="table-fn"}                   2,621 (13.8)          2,689 (15.9)                                     1.01 (0.95--1.07)   0.750
  Minor complications[^c^](#tblfn5){ref-type="table-fn"}                1,434 (7.6)           1,369 (8.1)                                      0.98 (0.90--1.06)   0.642
  Major complications[^d^](#tblfn6){ref-type="table-fn"}                1,419 (7.5)           1,503 (8.9)                                      1.00 (0.92--1.08)   1.000
   Superficial SSI                                                      994 (5.3)             848 (5.0)                                        0.95 (0.86--1.05)   0.312
   Deep SSI                                                             132 (0.7)             119 (0.7)                                        0.96 (0.74--1.24)   0.759
   Organ-specific SSI                                                   498 (2.6)             479 (2.8)                                        1.08 (0.94--1.23)   0.277
   Wound disruption                                                     165 (0.9)             116 (0.7)                                        0.69 (0.54--0.89)   0.003
   Pneumonia                                                            273 (1.4)             390 (2.3)                                        1.23 (1.04--1.45)   0.016
   Re-intubation                                                        246 (1.3)             321 (1.9)                                        1.04 (1.04--1.04)   \<0.001
   Pulmonary embolism                                                   97 (0.5)              135 (0.8)                                        1.25 (0.95--1.65)   0.111
   Ventilator dependence                                                213 (1.1)             216 (1.3)                                        0.89 (0.89--0.89)   \<0.001
   Renal progressive insufficiency                                      102 (0.5)             100 (0.6)                                        0.91 (0.68--1.22)   0.526
   ARF                                                                  66 (0.4)              66 (0.4)                                         0.94 (0.94--0.95)   \<0.001
   CVA                                                                  45 (0.2)              70 (0.4)                                         1.14 (0.77--1.69)   0.513
   Coma                                                                 5 (0)                 0 (0)                                            NA                  
   Cardiac arrest                                                       76 (0.4)              94 (0.6)                                         1.04 (0.76--1.43)   0.806
   MI                                                                   115 (0.6)             141 (0.8)                                        0.94 (0.73--1.22)   0.631
   Sepsis                                                               405 (2.1)             406 (2.4)                                        1.06 (0.91--1.23)   0.454
   Septic shock                                                         212 (1.1)             222 (1.3)                                        0.95 (0.78--1.16)   0.610
   UTI                                                                  359 (1.9)             393 (2.3)                                        0.91 (0.78--1.06)   0.230
   DVT                                                                  150 (0.8)             209 (1.2)                                        1.28 (1.02--1.60)   0.033
   Re-operation                                                         56 (0.3)              41 (0.2)                                         0.77 (0.50--1.18)   0.235
  30-day mortality                                                      175 (0.9)             251 (1.5)                                        1.04 (0.85--1.27)   0.703
  Operation time of colectomy[^e^](#tblfn7){ref-type="table-fn"}, min                                                                                              
   \<160                                                                8,955 (47.3)          12,107 (71.5)                                    1 \[Reference\]     
   ≥160                                                                 9,981 (52.7)          4,820 (28.5)                                     0.38 (0.36--0.39)   \<0.001
  Length of hospital stay[^e^](#tblfn7){ref-type="table-fn"}, days                                                                                                 
   \<5                                                                  8,740 (46.2)          6,945 (41.0)                                     1 \[Reference\]     
   ≥5                                                                   10,196 (53.8)         9,982 (59.0)                                     1.10 (1.05--1.15)   \<0.001

LCC, left colon cancer; RCC, right colon cancer; OR, odds ratio; CI, confidential interval; SSI, surgical-site infection; ARF, acute renal failure, CVA, cerebrovascular accident; MI, myocardial infraction; UTI, urinary-tract infection; DVT, deep vein thrombosis; NA, not applicable.

Adjusted for age, sex, race, smoking, functional status, American Society of Anesthesiologists classification, body mass index, weight loss \>10%, diabetes, congestive heart failure, previous cardiac surgery, previous percutaneous coronary intervention, myocardial infraction, transient ischemic attack, hypertension, pneumonia, chronic obstructive pulmonary disease, cerebrovascular accident, and hemiplegia.

Including one or more of the complications listed in [Table 2](#goz033-T2){ref-type="table"}.

Including superficial SSI, UTI, DVT, and/or thrombophlebitis.

Including deep SSI, organ-space SSI, wound disruption, pneumonia, re-intubation, pulmonary embolism, greater than 48-hour post-operative ventilator-assisted respiration, progressive renal insufficiency, ARF, CVA, cardiac arrest requiring cardiopulmonary resuscitation, MI, sepsis, and septic shock.

Median value was based on the distribution of patients with LCC colectomy.

Association between outcomes and locations according to anemia and blood transfusion
------------------------------------------------------------------------------------

Both anemia and transfusion were independently associated with an increased risk of post-operative complications and death based on multivariate analyses **(**[Table 3](#goz033-T3){ref-type="table"}**)**. The observed increased risks of complications seemed greater among LCC than RCC patients. We also found significant joint effects of anemia and transfusion on complications and 30-day mortality. Among LCC patients without anemia, patients receiving transfusions had higher risk of any complications (OR* *=* *3.51; 95% CI* *=* *2.55--4.85; *P *\<* *0.001), minor complications (OR* *=* *2.54; 95% CI* *=* *1.63--3.97; *P *\<* *0.001), and major complications (OR* *=* *5.31; 95% CI* *=* *3.68--7.64; *P *\<* *0.001) than those receiving transfusions **(**[Table 3](#goz033-T3){ref-type="table"}**)**. The high risks of any complications, minor complications, and major complications were also observed in patients with mild and severe anemia who underwent a transfusion. Similar patterns were observed for RCC patients (OR* *=* *3.74; 95% CI* *=* *2.50--5.59; *P *\<* *0.001 for any complication; OR* *=* *2.27; 95% CI* *=* *1.24--4.15; *P *=* *0.008 for minor complications; OR* *=* *5.64; 95% CI* *=* *3.61--8.79; *P *\<* *0.001 for major complications) ([Table 3](#goz033-T3){ref-type="table"}). The risk of 30-day mortality was the highest among LCC patients without anemia but who had a transfusion (OR* *=* *6.97; 95% CI* *=* *3.07--15.80; *P *\<* *0.001), followed by patients with mild anemia and transfusion (OR* *=* *4.48; 95% CI* *=* *2.75--7.27; *P *\<* *0.001). Similarly, in RCC patients, the risk of 30-day mortality was the highest among patients without anemia but with transfusion (OR* *=* *4.91; 95% CI* *=* *1.88--12.85; *P *=* *0.001), followed by patients with severe anemia but no transfusion (OR* *=* *3.18; 95% CI* *=* *1.54--6.57; *P *=* *0.002) and patients with mild anemia and transfusion (OR* *=* *3.10; 95% CI* *=* *2.00--4.81; *P *\<* *0.001). Similar associations between anemia/transfusion and overall outcomes were found between open and laparoscopic groups ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}) and between patients who had longer and shorter operation times ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}), and all models fit well ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}).

###### 

Association between surgical outcomes and colon-cancer locations according to anemia and blood transfusion

  Variable                          No complications   Any complication^b^   Minor complications^c^  Major complications^d^    30-day mortality                                                                                                  
  -------------------------------- ------------------ --------------------- ------------------------ ------------------------ ------------------ ------------------- --------- -------- ------------------- --------- ----- -------------------- ---------
  LCC                                                                                                                                                                                                                                            
  Anemia                                                                                                                                                                                                                                         
   No                                    9,794               1, 279             1 \[Reference\]                                      728           1 \[Reference\]               634      1 \[Reference\]              59     1 \[Reference\]    
   Mild                                  6,318               1, 284            1.26 (1.15--1.38)     \<0.001                         680          1.22 (1.08--1.37)  0.001       744     1.41 (1.24--1.59)  \<0.001    113   1.55 (1.09--2.21)   0.015
   Severe                                 203                  58              1.27 (0.92--1.74)     0.146                            26          1.19 (0.77--1.84)  0.433        41     1.54 (1.06--2.24)  0.023       3    0.76 (0.23--2.54)   0.653
  Transfusion                                                                                                                                                                                                                                    
   No                                    15,567              2, 300             1 \[Reference\]                                     1, 312         1 \[Reference\]              1, 184    1 \[Reference\]              136    1 \[Reference\]    
   Yes                                    748                  321             2.40 (2.06--2.78)     \<0.001                         122          1.66 (1.34--2.04)  \<0.001     235     3.22 (2.71--3.82)  \<0.001    39    3.05 (2.05--4.51)   \<0.001
  Anemia/transfusion                                                                                                                                                                                                                             
   No anemia, no transfusion             9,662               1, 221             1 \[Reference\]                                      704           1 \[Reference\]               592      1 \[Reference\]              52     1 \[Reference\]    
   No anemia, transfusion                 132                  58              3.51 (2.55--4.85)     \<0.001                          24          2.54 (1.63--3.97)  \<0.001      42     5.31 (3.68--7.64)  \<0.001     7    6.97 (3.07--15.80)  \<0.001
   Mild anemia, no transfusion           5,779               1, 049            1.29 (1.17--1.41)     \<0.001                         590          1.24 (1.09--1.40)  0.001       573     1.46 (1.29--1.66)  \<0.001    83    1.74 (1.20--2.52)   0.003
   Mild anemia, transfusion               539                  235             2.89 (2.43--3.44)     \<0.001                          90          1.96 (1.53--2.50)  \<0.001     171     4.32 (3.52--5.29)  \<0.001    30    4.48 (2.75--7.27)   \<0.001
   Severe anemia, no transfusion          126                  30              1.62 (1.07--2.44)     0.023                            18          1.67 (1.00--2.77)  0.050        19     2.13 (1.30--3.51)  0.003       1    0.86 (0.12--6.33)   0.881
   Severe anemia, transfusion              77                  28              2.42 (1.55--3.78)     \<0.001                          8           1.20 (0.57--2.51)  0.631        22     3.90 (2.38--6.39)  \<0.001     2    2.40 (0.57--10.20)  0.233
  *P*-value for interaction                                                          0.002                                                              0.006                                 \<0.001                               0.01         
  RCC                                                                                                                                                                                                                                            
  Anemia                                                                                                                                                                                                                                         
   No                                    5,042                 787              1 \[Reference\]                                      434           1 \[Reference\]               415      1 \[Reference\]              47     1 \[Reference\]    
   Mild                                  8,788               1, 818            1.13 (1.02--1.24)     0.019                           891          1.04 (0.92--1.18)  0.531      1, 033   1.16 (1.02--1.32)  0.024      190   1.38 (0.98--1.94)   0.065
   Severe                                 408                  84              0.87 (0.67--1.13)     0.296                            44          0.93 (0.66--1.31)  0.678        55     0.93 (0.68--1.29)  0.650      14    1.55 (0.81--2.97)   0.186
  Transfusion                                                                                                                                                                                                                                    
   No                                    13,078              2, 267             1 \[Reference\]                                     1, 192         1 \[Reference\]              1, 217    1 \[Reference\]              196    1 \[Reference\]    
   Yes                                   1,160                 422             1.97 (1.73--2.24)     \<0.001                         177          1.63 (1.37--1.95)  \<0.001     286     2.43 (2.08--2.82)  \<0.001    55    2.01 (1.46--2.79)   \<0.001
  Anemia/transfusion                                                                                                                                                                                                                             
   No anemia, no transfusion             4,972                 747              1 \[Reference\]                                      421           1 \[Reference\]               384      1 \[Reference\]              42     1 \[Reference\]    
   No anemia, transfusion                  70                  40              3.74 (2.50--5.59)     \<0.001                          13          2.27 (1.24--4.15)  0.008        31     5.64 (3.61--8.79)  \<0.001     5    4.91 (1.88--12.85)  0.001
   Mild anemia, no transfusion           7,866               1, 477            1.16 (1.05--1.28)     0.004                           744          1.04 (0.91--1.19)  0.565       806     1.22 (1.07--1.39)  0.003      144   1.45 (1.02--2.08)   0.038
   Mild anemia, transfusion               922                  341             2.21 (1.89--2.57)     \<0.001                         147          1.74 (1.42--2.14)  \<0.001     227     2.79 (2.32--3.37)  \<0.001    46    3.10 (2.00--4.81)   \<0.001
   Severe anemia, no transfusion          240                  43              1.09 (0.77--1.52)     0.627                            27          1.23 (0.81--1.86)  0.331        27     1.29 (0.85--1.96)  0.232      10    3.18 (1.54--6.57)   0.002
   Severe anemia, transfusion             168                  41              1.43 (1.00--2.04)     0.050                            17          1.09 (0.65--1.82)  0.744        28     1.85 (1.21--2.82)  0.005       4    1.48 (0.52--4.24)   0.463
  *P*-value for interaction                                                         \<0.001                                                             0.03                                  \<0.001                              0.004         

LCC, left colon cancer; RCC, right colon cancer; OR, odds ratio; CI, confidential interval.

Adjusted for age, sex, race, smoking, functional status, American Society of Anesthesiologists classification, body mass index, weight loss \>10%, diabetes, congestive heart failure, previous cardiac surgery, previous percutaneous coronary intervention, transient ischemic attack, hypertension, pneumonia, myocardial infraction, chronic obstructive pulmonary disease, cerebrovascular accident, and hemiplegia.

Including one or more of the complications listed in [Table 2](#goz033-T2){ref-type="table"}.

Including superficial surgical-site infection, deep vein thrombosis, urinary-tract infection, and/or thrombophlebitis.

Including deep surgical-site infection, organ-space surgical-site infection, wound disruption, pneumonia, re-intubation, pulmonary embolism, greater than 48-hour post-operative ventilator-assisted respiration, progressive renal insufficiency, acute renal failure, cerebrovascular accident, cardiac arrest requiring cardiopulmonary resuscitation, myocardial infraction, sepsis, and septic shock.

Discussion
==========

This study investigated the joint effect of pre-operative anemia and perioperative transfusion by tumor location on post-operative outcomes in colon-cancer patients undergoing colectomy. A novel finding from the study was that patients without anemia but with transfusion experienced the highest risk of complications and mortality, followed by patients with mild or severe anemia and with blood transfusion, suggesting that a conservative transfusion practice should be considered during colectomy.

The exact mechanisms linking transfusion and adverse outcomes are not fully understood; several phenomena have been suggested \[[@goz033-B20]\]. For example, transfusion induces immunosuppression, which results in an increased susceptibility to infections \[[@goz033-B21], [@goz033-B22]\]. Transfusion can also increase inflammation by inducing alloimmunization \[[@goz033-B23]\]. As expected, this study demonstrated that perioperative transfusion was associated with increased risk of post-operative complications and mortality regardless of anemia status in patients who underwent colectomy. Although pre-operative anemia was reported as an independent predictor on post-operative outcomes, the combined effect appears more closely related to blood transfusion. An earlier study based on NSQIP data reported an increased risk of complications and mortality associated with pre-operative transfusion in patients who underwent colectomy \[[@goz033-B13]\]. To eliminate potential confounding from pre-operative transfusion, our study population excluded patients with a history of pre-operative transfusion.

Our study found that the risk of post-operative complications associated with transfusion varied by anemia status. There are reasons for transfusion in clinical practice. For example, patients with significant blood loss during or after colectomy \[[@goz033-B24]\], patients with certain conditions (liver disease, etc.) affecting the production of clotting proteins \[[@goz033-B25]\], patients who underwent chemotherapy, and/or patients with certain heart or lung diseases \[[@goz033-B26], [@goz033-B27]\] were all transfusion candidates. It is also possible that the underlying clinical reasons for transfusion resulted in adverse outcomes rather than the transfusion itself. Due to a lack of information on the reason for blood transfusion in our patient cohort, we were unable to evaluate this association. Furthermore, as the decision to transfuse a patient depends on an individual evaluation by a physician, the decision is also influenced by regulations, fear of future litigation, and public expectations in addition to clinical evidence \[[@goz033-B28]\]. On the other hand, conditions that suggest a blood transfusion might further worsen of blood transfusion's adverse effect on outcomes, even after adjusting demographics and comorbidities.

Our study's findings provide a strong argument for a more optimal and prudent transfusion practice, suggesting a restrictive rather than liberal transfusion strategy \[[@goz033-B29], [@goz033-B30]\]. Alternatives to transfusion have been long anticipated. Pre-operative ferric carboxymaltose treatment has been shown to significantly reduce transfusion requirements and hospital length of stay in colon-cancer patients with anemia and improves hemoglobin response at 12 weeks in patients who underwent gastrectomy, suggesting that it could be a viable alternative to transfusion when a rapid increase in the hemoglobin level is required \[[@goz033-B31], [@goz033-B32]\].

In addition to providing strong evidence for the joint effect of pre-operative anemia and perioperative transfusion on post-operative outcomes of colectomy, the present study also raised a concern about the transfusion criteria for patients undergoing colectomy for cancer, specifically for patients with no anemia. The most common reason for transfusion in such patients is either large amounts of blood loss during surgery or major bleeding complications after surgery. Nevertheless, this reason cannot be explained by the NSQIP, which does not collect any data on blood loss.

A common concern is that case complexity is associated with transfusion requirements. Without a reliable measurement of case complexity, the operation time could serve as a surrogate indicator. Further, laparoscopic surgery was also associated with lower transfusion requirements than an open approach \[[@goz033-B8]\] likely because open surgery may amplify the effect of anemia and blood transfusion. In comparison, we found that patients who experienced open surgery or longer operation time did not show different patterns.

Another interesting finding was the stronger association of anemia and transfusion with complications and mortality in LCC patients than in RCC patients. To our knowledge, this result has not been described in previous studies. A previous study with a relatively small sample size (*n* = 4,875) reported comparable complication rates between LCC and RCC patients undergoing colectomy with the exception of superficial SSI, which was found to be less common in RCC colectomy \[[@goz033-B33]\]. Reasons for this difference may be associated with a delay in the diagnosis and associated advanced stage of RCC \[[@goz033-B34]\]. Additionally, the occurrence rate of mild and severe anemia was lower in LCC than in RCC patients. We suspect that LCC patients exhibited a better physical condition and earlier presentation than RCC patients.

Our study had several limitations related to its retrospective design. Although the NSQIP is a large worldwide database, the samples included in our study are likely heterogeneous and subject to selection bias because the patients were all deemed fit for surgery. We were unable to consider the specific therapy for each patient. Additionally, the NSQIP does not provide detailed data on the subtype of anemia, duration prior to surgery, volume of blood transfusion, and estimated blood loss during the operation. Sorting these factors out of such a large database would be impractical. Finally, the database does not define the transfusion criteria or rationale.

Conclusions
===========

The study found that perioperative blood transfusion posed a greater risk of complications and mortality regardless of anemia status, suggesting that a perioperative blood transfusion should be judiciously administered, particularly in patients with mild anemia or without anemia.
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